Date:5/7/2009

(In thousands, except per share data) (Unaudited) Reconciliation of Net Income to Diluted FFO Three Months Ended March 31, ---------------- 2009 2008 ---- ---- Net income $50,633 $37,446 Preferred stock dividends (1,452) (2,062) Net (income) loss attributable to noncontrolling interests (27) 9 Real estate related depreciation and amortization 30,808 28,589 Depreciation in income from unconsolidated joint ventures 1,307 1,115 Gains on sale of facilities, net (21,152) (10,866) ------- ------- FFO available to NHP common stockholders 60,117 54,231 Series B preferred dividend add-back 1,452 2,062 ----- ----- Diluted FFO $61,569 $56,293 ======= ======= Weighted average shares outstanding for diluted FFO: Diluted weighted average shares outstanding (1) 104,451 95,783 Series B preferred stock conversion add-back if not already converted 3,358 4,728 ----- ----- Fully diluted
'/>"/>

SOURCE Nationwide Health Properties, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related medicine news :

1. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
2. PLC Systems Reports First Quarter 2009 Results
3. Perrigo Reports Record Third Quarter
4. Symmetry Medical Reports First Quarter 2009 Financial Results
5. Orchid Cellmark Reports Improved First Quarter 2009 Financial Results
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Isis Reports Strong Financial Results and Highlights for First Quarter of 2009
8. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
9. Stereotaxis Reports First Quarter 2009 Financial Results
10. Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
11. The Ensign Group Reports First Quarter 2009 Earnings of $0.38 per Share; Reaffirms 2009 Guidance